Cleared Traditional

K021218 - ELECSYS CORTISOL TEST SYSTEM

K021218 is an FDA 510(k) clearance for ELECSYS CORTISOL TEST SYSTEM, manufactured by Roche Diagnostics Corp.. The device is a Class 2 Chemistry device with product code JFT cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K021218 · Roche Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2002
Decision
145d
Days
Class 2
Risk

K021218 is an FDA 510(k) clearance for the ELECSYS CORTISOL TEST SYSTEM. Classified as Fluorometric, Cortisol (product code JFT), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on September 9, 2002 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1205 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics Corp. devices

FDA 510(k) Submission Details - K021218

510(k) Number K021218 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 2002
Decision Date September 09, 2002
Days to Decision 145 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d slower than avg
Panel avg: 88d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JFT Device Classification - Class 2, Special Controls

Product Code JFT Fluorometric, Cortisol
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1205
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JFT Fluorometric, Cortisol

All 19
Devices cleared under the same product code (JFT) and FDA review panel - the closest regulatory comparables to K021218.
ADVIA Centaur Cortisol (COR) Assy
K142723 · Siemens Healthcare Diagnostics, Inc. · Mar 2015
ARCHITECT CORTISOL ASSAY
K062204 · Seradyn, Inc. · Sep 2006
AXSYM CORTISOL ASSAY
K033731 · Fujirebio Diagnostics,Inc. · Feb 2004
ACS CORTISOL IMMUNOASSAY
K962559 · Ciba Corning Diagnostics Corp. · Nov 1996
AIA-PACK CORT ASSAY
K954591 · Tosoh Medics, Inc. · Dec 1995
CIDBA CORNING ACS CORTISOL IMMUNOASSAY
K934317 · Ciba Corning Diagnostics Corp. · May 1994